Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
OSE-127/Lusvertikimab
FR104/VEL-101
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Regulated information
Financial documents
General Shareholders’ meetings
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Projects Archives
January 2024
JPM HEALTHCARE CONFERENCE
December 2023
INVEST SECURITIES BIOMED FORUM 2024
October 2023
HealthTech Innovation Days
September 2023
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 2023
Protein & Antibody Engineering Summit (PEGS) Europe Summit
September 2023
Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
September 2023
CICON23 – International Cancer Immunotherapy Conference
September 2023
European MidCap Event, 23rd Edition
September 2023
H.C. Wainwright 25th Annual Global Investment Conference
September 2023
23RD ANNUAL BIOTECH IN EUROPE FORUM FOR GLOBAL PARTNERING & INVESTMENT
Précédent
1
2
3
4
5
Suivant